Abstract

Alzheimer’s disease (AD) presents a complex clinical challenge, necessitating exploration of innovative therapeutic approaches. This paper investigates the integration of a medicinal Cannabis protocol, featuring specific THC and CBD ratios, within the care plans of three individuals diagnosed with AD. Drawing upon existing literature and detailed case studies, we evaluate the protocol’s impact on symptom progression, quality of life, and caregiver burden. Our analysis suggests promising therapeutic benefits of medicinal Cannabis in mitigating symptoms associated with AD, underscoring the importance of further research in this evolving field

Keywords

alzheimer’s disease, medicinal cannabis, THC, CBD, symptom management, caregiver burden, neuroprotection, anti-inflammatory properties